A better characterized member of this family, ARRDC3, is a breast and prostate cancer suppressor; lower expression of ARRDC3 was significantly associated with high aggressiveness and metastasis in prostate cancer cells [65,66]. Here, ARRDC3 is linked to prostate carcinoma.